Performance of the PROMIS After Operative Interventions for Shoulder Instability by Hajewski, Christina J. et al.
University of Kentucky 
UKnowledge 
Orthopaedic Surgery and Sports Medicine 
Faculty Publications Orthopaedic Surgery and Sports Medicine 
5-2019 
Performance of the PROMIS After Operative Interventions for 
Shoulder Instability 
Christina J. Hajewski 
University of Iowa 
Natalie A. Glass 
University of Iowa 
Robert W. Westermann 
University of Iowa 
Matthew Bollier 
University of Iowa 
Brian R. Wolf 
University of Iowa 
See next page for additional authors 
Follow this and additional works at: https://uknowledge.uky.edu/orthopaedicsurgery_facpub 
 Part of the Orthopedics Commons, and the Sports Sciences Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
Hajewski, Christina J.; Glass, Natalie A.; Westermann, Robert W.; Bollier, Matthew; Wolf, Brian R.; and 
Hettrich, Carolyn, "Performance of the PROMIS After Operative Interventions for Shoulder Instability" 
(2019). Orthopaedic Surgery and Sports Medicine Faculty Publications. 22. 
https://uknowledge.uky.edu/orthopaedicsurgery_facpub/22 
This Article is brought to you for free and open access by the Orthopaedic Surgery and Sports Medicine at 
UKnowledge. It has been accepted for inclusion in Orthopaedic Surgery and Sports Medicine Faculty Publications by 
an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
Performance of the PROMIS After Operative Interventions for Shoulder Instability 
Abstract 
Background: The Patient-Reported Outcomes Measurement Information System (PROMIS) was 
developed to capture patient-reported outcomes (PROs) in an efficient manner. Few studies have 
assessed this instrument postoperatively. 
Purpose: To compare the PROMIS Physical Function computer adaptive test (PROMIS PF CAT) and Upper 
Extremity (PROMIS UE) item bank to other previously validated PRO instruments and to evaluate ceiling 
and floor effects and construct validity responsiveness in patients who underwent operative interventions 
for shoulder instability. 
Study Design: Cohort study (diagnosis); Level of evidence, 2. 
Methods: A total of 72 patients who underwent operative interventions for shoulder instability completed 
the American Shoulder and Elbow Surgeons (ASES) assessment form, Marx shoulder activity scale 
(Marx), 36-Item Short Form Health Survey physical function (SF-36 PF) and general health (SF-36 GH), 
Western Ontario Shoulder Instability Index (WOSI), PROMIS PF CAT, and PROMIS UE before surgery and 
then at 6 weeks and 6 months postoperatively. Correlation coefficients were calculated among these 
tools. The effect size of change was also calculated for each tool at each time point. A total of 91 
patients who had also undergone surgery for shoulder instability completed these PRO instruments 2 
years postoperatively. The percentage of patients hitting the ceiling and floor effects of each of the PRO 
instruments was calculated at all time points. 
Results: The PROMIS PF CAT demonstrated excellent-good correlation with the SF-36 PF at all 
postoperative time points (0.61 at 6 weeks, 0.68 at 6 months, and 0.64 at 2 years; P < .01 for all). The 
PROMIS UE showed excellent correlation with the ASES at 6 weeks postoperatively (0.73, P < .01). Both 
the PROMIS PF CAT and PROMIS UE demonstrated the ability to detect change after surgical 
interventions with a medium to large effect size. The PROMIS UE demonstrated a ceiling effect at 6 
months (68.1%) and 2 years (67.0%) postoperatively. The PROMIS PF CAT demonstrated no ceiling effect 
at any time point. 
Conclusion: The PROMIS PF CAT demonstrated good to excellent correlation with other previously 
validated PRO instruments that assess physical function in patients with shoulder instability 
postoperatively. The PROMIS UE demonstrated good correlation with other PRO tools but had a 
significant ceiling effect and is not recommended for this patient population. Both tools demonstrated an 
ability to detect change after surgical interventions with a good effect size. 
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Performance of the PROMIS After Operative
Interventions for Shoulder Instability
Christina J. Hajewski,*† MD, Natalie A. Glass,† PhD, Robert W. Westermann,† MD,
Matthew Bollier,† MD, Brian R. Wolf,† MD, MS, and Carolyn Hettrich,‡ MD, MPH
Investigation performed at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
Background: The Patient-Reported Outcomes Measurement Information System (PROMIS) was developed to capture patient-
reported outcomes (PROs) in an efficient manner. Few studies have assessed this instrument postoperatively.
Purpose: To compare the PROMIS Physical Function computer adaptive test (PROMIS PF CAT) and Upper Extremity (PROMIS
UE) item bank to other previously validated PRO instruments and to evaluate ceiling and floor effects and construct validity
responsiveness in patients who underwent operative interventions for shoulder instability.
Study Design: Cohort study (diagnosis); Level of evidence, 2.
Methods: A total of 72 patients who underwent operative interventions for shoulder instability completed the American Shoulder
and Elbow Surgeons (ASES) assessment form, Marx shoulder activity scale (Marx), 36-Item Short Form Health Survey physical
function (SF-36 PF) and general health (SF-36 GH), Western Ontario Shoulder Instability Index (WOSI), PROMIS PF CAT, and
PROMIS UE before surgery and then at 6 weeks and 6 months postoperatively. Correlation coefficients were calculated among
these tools. The effect size of change was also calculated for each tool at each time point. A total of 91 patients who had also
undergone surgery for shoulder instability completed these PRO instruments 2 years postoperatively. The percentage of patients
hitting the ceiling and floor effects of each of the PRO instruments was calculated at all time points.
Results: The PROMIS PF CAT demonstrated excellent-good correlation with the SF-36 PF at all postoperative time points (0.61 at
6 weeks, 0.68 at 6 months, and 0.64 at 2 years; P < .01 for all). The PROMIS UE showed excellent correlation with the ASES at 6
weeks postoperatively (0.73, P < .01). Both the PROMIS PF CAT and PROMIS UE demonstrated the ability to detect change after
surgical interventions with a medium to large effect size. The PROMIS UE demonstrated a ceiling effect at 6 months (68.1%) and 2
years (67.0%) postoperatively. The PROMIS PF CAT demonstrated no ceiling effect at any time point.
Conclusion: The PROMIS PF CAT demonstrated good to excellent correlation with other previously validated PRO instruments
that assess physical function in patients with shoulder instability postoperatively. The PROMIS UE demonstrated good correlation
with other PRO tools but had a significant ceiling effect and is not recommended for this patient population. Both tools demon-
strated an ability to detect change after surgical interventions with a good effect size.
Keywords: outcomes; shoulder; instability; PROMIS
Patient-reported outcomes (PROs) are becoming increas-
ingly important in our current health care delivery system.
Identifying tools to accurately and efficiently capture PROs
will help providers better understand patients’ perspective
of their abnormality and treatment. These tools are also
valuable to providers by allowing them to appropriately
counsel patients about expected outcomes before and after
operative interventions.
Shoulder instability is not uncommon, especially in
young and athletic populations. The incidence of anterior
instability has been shown to be between 11.2 per
100,000 person-years18 and 23.9 per 100,000 person-
years19 in the United States. These patients are often
young and male, and collision and overhead athletes
have a higher risk.7,8
Previously validated PRO tools used for the evaluation of
patients with shoulder instability include the American
Shoulder and Elbow Surgeons (ASES) assessment form,12
the Western Ontario Shoulder Instability Index (WOSI),11
and the Marx shoulder activity scale.5 Other PRO instru-
ments that address general health–related quality of life
have also been used in the assessment of patients with
shoulder instability, such as the 36-Item Short Form
Health Survey, which includes subscales for physical func-
tion (SF-36 PF), general health (SF-36 GH), vitality, bodily
pain, physical role functioning, emotional role functioning,
social role functioning, and mental health,13 and the Euro-
Qol–5 Dimensions (EQ-5D) questionnaire.10 Each of these
instruments includes several domains to evaluate a
patient’s outcome, including physical function, pain, and
The Orthopaedic Journal of Sports Medicine, 7(5), 2325967119846920
DOI: 10.1177/2325967119846920
ª The Author(s) 2019
1
This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (http://creativecommons.org/
licenses/by-nc-nd/4.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are
credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For article reuse guidelines, please visit SAGE’s website at
http://www.sagepub.com/journals-permissions.
general health. The ideal tool should have a low respondent
burden and have the ability to detect change before and
after an intervention.
The Patient-Reported Outcomes Measurement Informa-
tion System (PROMIS) was developed by the National
Institutes of Health in an effort to improve the assessment
of PROs by creating a tool that is highly reliable and precise
while decreasing the burden on both patients and health
care providers. Specifically, the PROMIS Physical Function
computer adaptive test (PROMIS PF CAT) has been inves-
tigated in multiple patient populations with orthopaedic
abnormalities.3,4,17 The PROMIS Upper Extremity (PRO-
MIS UE) item bank has also been utilized to study PROs in
patients with rotator cuff abnormalities2,16 and those
undergoing shoulder arthroplasty.6 Both of these tools have
been previously investigated in patients with a diagnosis of
shoulder instability before operative interventions. It was
shown that there was good to excellent correlation with
other legacy upper extremity PRO instruments; however,
the PROMIS UE had significant ceiling effects in patients
aged 21 years.3 Fewer studies have looked at these 2 tools
to evaluate patients after surgery when activity levels and
use of the operative extremity should be higher and pain
levels should be improved.
For patients undergoing a surgical intervention, it is of
utmost importance to have a PRO instrument that can cap-
ture a meaningful change to judge the impact of the surgi-
cal intervention. Ideally, a PRO tool should have the ability
both to detect change over a time frame (responsiveness)
and to correspond to changes in a reference PRO instru-
ment (construct validity). For these reasons, we aimed to
investigate the PROMIS PF CAT and PROMIS UE in
patients with shoulder instability before and after opera-
tive interventions. We hypothesized that (1) these tools can
detect a change before and after an intervention and dem-
onstrate a large effect size of that change; (2) the PROMIS
UE may show a ceiling effect after shoulder stabilization in
young patients; and (3) there would be convergent validity
with other measures of physical function, such as the SF-36
PF, ASES, and WOSI, and divergent validity with mea-
sures of general health, such as the SF-36 GH and EQ-5D.
METHODS
This study was approved by our institutional review board
and was determined to be HIPAA (Health Insurance Por-
tability and Accountability Act) compliant. Patients
enrolled in our institution’s prospective shoulder instability
database are asked to complete the ASES,WOSI, Marx, SF-
36 (PF and GH subscales included), EQ-5D, PROMIS PF
CAT, and PROMIS UE preoperatively and at 6 weeks,
6 months, and 2 years postoperatively. Data from patients
enrolled in the database from January 21, 2015, to Novem-
ber 28, 2016, were extracted. A total of 96 patients were
identified from this data extraction, and 72 were found to
have complete preoperative as well as 6-week and 6-month
postoperative data available for longitudinal analysis. Only
18 patients from this group had complete longitudinal data
from preoperatively to 2 years postoperatively. Therefore, a
second group of patients was identified from the database
who were eligible for 2-year follow-up from June 9, 2015, to
November 26, 2017. A total of 106 patients were identified
in this time frame, and 91 patients had complete data avail-
able at 2 years postoperatively for cross-sectional analysis.
Eighteen of these patients had preoperative data and over-
lapped with the longitudinal group. Patient demographic
data including age, body mass index (BMI), sex, operative
side, and procedure type were extracted from patient
records. The typical rehabilitation protocol followed the
Multicenter Orthopaedic Outcomes Network (MOON)
shoulder instability protocols, which included starting
physical therapy 2 weeks postoperatively and progressing
to active range of motion and resisted isometric exercises by
6 weeks after surgery.14
Statistical analysis was carried out to determine
Spearman correlation coefficients between the PROMIS
PF CAT and PROMIS UE with the previously mentioned
legacy PRO instruments: ASES, WOSI, SF-36, Marx,
and EQ-5D. Correlations were described as excellent
(>0.7), excellent-good (0.61-0.7), good (0.4-0.6), or poor
(0.2-0.39).9 Responsiveness to change was assessed using
the effect size (Cohen d) and standardized response mean
at 6 weeks and 6 months postoperatively. Values were
defined as small (0.2), medium (0.5), or large (0.8).15 The
percentage of patients achieving the lowest (floor) and
highest (ceiling) possible scores of each PRO tool was cal-
culated, and the presence of a floor or ceiling effect was
determined if >15% of patients were achieving these
values. SAS statistical software (version 9.4; SAS Institute)
was used for analyses, with P < .05 considered statistically
significant.
RESULTS
Of the 72 patients with data available for longitudinal anal-
ysis, the mean age was 22.1 years (range, 14-44 years), 79%
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were male, and the mean BMI was 26.6 kg/m2 (range, 20-38
kg/m2). Of the 91 patients who had complete data at 2 years
postoperatively, the mean age was 24.8 years (range, 17-56
years), 80% were male, and the mean BMI was 26.4 kg/m2
(range, 20-42 kg/m2). Demographics and procedures per-
formed can be found in Table 1. The median number of
questions answered was 7 questions for the PROMIS PF
CAT (range, 3-12) and 16 questions for the PROMIS UE.
Among the other PRO tools, there were 10 questions for the
SF-36 PF, 5 questions for the SF-36 GH, 10 questions for
the ASES, 7 questions for the Marx, 5 questions for the
EQ-5D, and 21 questions for the WOSI.
PROMIS Changes After Surgery
The PROMIS UE and PROMIS PF CAT demonstrated a
statistically significant change between the 3 time points
used in longitudinal analysis: preoperatively, 6 weeks post-
operatively, and 6 months postoperatively. Scores initially
decreased (PROMIS PF CAT: 51.48 to 45.42, P < .01; PRO-
MIS UE: 44.02 to 35.14, P < .01) at 6 weeks postoperatively
and then increased above the preoperative scores at
6 months postoperatively (PROMIS PF CAT: to 57.18,
P < .01; PROMIS UE: to 52.15, P < .01). The effect size
(Cohen d) wasmedium to large at each time point (PROMIS
UE: –1.05 ± 0.30 from preoperatively to 6 weeks and 1.09 ±
0.33 from preoperatively to 6 months; PROMIS PF CAT:
–0.94 ± 0.33 from preoperatively to 6 weeks and 0.76 ± 0.32
from preoperatively to 6 months). Results are summarized
in Table 2.
Floor and Ceiling Effects
Ceiling effects were demonstrated at 6 months (68.1%) and
2 years (67.0%) postoperatively for the PROMIS UE.
There was no ceiling effect for the PROMIS PF CAT at any
time point. Ceiling effects were also present at 6 months
and 2 years postoperatively for the ASES (23.6% and
39.0%, respectively), SF-36 PF (41.7% and 69.0%, respec-
tively), and EQ-5D (48.6% and 39.0%, respectively). A
subgroup analysis of patients aged 21 years (n ¼ 38)
demonstrated even larger ceiling effects at 6 months
(71.1%) and 2 years (81.0%) postoperatively. The PROMIS
UE has been expanded to a CAT to include 46 items (PRO-
MIS UE CAT v 2.0). We had a total of 18 patients who
completed this updated version of the PROMIS UE at 2
years postoperatively. Analysis on this group still demon-
strated a ceiling effect of 44.0%. These results are summa-
rized in Table 3.
Correlation With Previously Validated Instruments
The PROMIS UE demonstrated the strongest correlation
with legacy PRO tools used in shoulder instability, such
as the ASES, WOSI, and SF-36 PF. It showed excellent
correlation with the ASES at 6 weeks postoperatively
(0.73, P < .01) and excellent-good correlation with the
WOSI (0.62, P < .01) and SF-36 PF (0.68, P < .01) at
6 weeks postoperatively. It demonstrated good correlation
at 6 months and 2 years postoperatively with the ASES
(0.54 and 0.58, respectively; P < .01), WOSI (0.48 and
0.58, respectively; P< .01), SF-36 PF (0.56 and 0.54, respec-
tively; P < .01), and EQ-5D (0.46 and 0.55, respectively;
P < .01). There was poor correlation at all time points with
the Marx (6 weeks: 0.06, P ¼ .61; 6 months: 0.26, P ¼ .03)
and SF-36 GH (6 weeks: 0.20, P ¼ .10; 6 months: 0.18,
P ¼ .12).
The PROMIS PF CAT showed excellent-good correlation
with the SF-36 PF at all time points (6 weeks: 0.61, P < .01;
6 months: 0.68, P < .01; 2 years: 0.64, P < .01). There was
excellent-good correlation at 2 years postoperatively with
the ASES (0.64, P < .01) and WOSI (0.62, P < .01). Results
are summarized in Table 4.
DISCUSSION
The present study determined that the PROMIS PF CAT
and PROMIS UE are able to adequately detect changes
after shoulder stabilization for instability. They both corre-
lated well with shoulder outcome measures that have been
previously validated. However, we did find significant ceil-
ing effects for the PROMIS UE. The PROMIS PF CAT did
not demonstrate floor or ceiling effects either before or after
shoulder stabilization for instability and could be consid-
ered for use in this population.
PROs are becoming increasingly important in our health
care delivery system and are being incorporated into health
care legislation. There is incredible value in identifying
PRO tools with a low respondent burden that can detect
meaningful change before and after an intervention. The
PROMIS was developed by the National Institutes of
Health to fulfill these requirements and has been shown
to correspond with other previously validated PRO tools for
patients with shoulder instability preoperatively; yet, the
PROMIS UE was found to have ceiling effects in patients
aged 21 years.3 Few reports in the literature have studied
the ability of the PROMIS to detect change before and after
surgical interventions, and no studies have investigated
this in patients with shoulder instability.
TABLE 1
Demographic Data and Procedures Performeda
Longitudinal
Group (n ¼ 72)
Cross-sectional
Group (n ¼ 91)
Age, y 22.1 (14-44) 24.8 (17-56)
Body mass index, kg/m2 26.6 (20-38) 26.4 (20-42)
Male sex, % 79 80
Procedure, n
Labral repair 40 58
Capsulorrhaphy/capsular
plication
10 7
Latarjet 5 5
Mixed 17 21
aData are reported as mean (range) unless otherwise indicated.
Data were available for the longitudinal group preoperatively and
at 6 weeks and 6months postoperatively and for the cross-sectional
group at 2 years postoperatively.
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This study aimed to examine the internal and external
responsiveness of 2 PROMIS tools after operative interven-
tions. Internal responsiveness demonstrates the ability of a
PRO to change before and after treatment.15 The PROMIS
PF CAT and PROMIS UE both demonstrated a statistically
significant change in scores preoperatively compared with
6 weeks and 6 months postoperatively. The PROMIS PF
CAT showed a medium to large effect size at 6 weeks and
6 months postoperatively compared with preoperatively,
and the PROMIS UE demonstrated a large effect size at
both time points. These effect sizes were comparable with
or larger than those of the legacy PRO tools evaluated in
this study.
External responsiveness can be assessed by examining
the correlation between a PRO tool and previously vali-
dated PRO instruments that measure a similar health
domain. In the current study, we examined the correlation
between the PROMIS PF CAT and PROMIS UE and legacy
PRO tools used to analyze shoulder function (WOSI, ASES,
and Marx) as well as general health and function (SF-36
PF, SF-36 GH, and EQ-5D). The PROMIS UE generally
demonstrated convergent validity with the other measures
of shoulder function (ASES, WOSI), while the PROMIS PF
CAT showed the most robust correlation with the SF-36 PF
at all postoperative time points. Therefore, the PROMIS PF
CAT could be administered in place of the SF-36 PF and
possibly the ASES and WOSI. There was generally diver-
gent validity between the PROMIS PF CAT and PROMIS
UE with other tools that measure other health domains,
such as general health and quality of life. This suggests
that co-administration of these other tools may need to be
continued when investigating these other health domains.
Ceiling and floor effects represent the percentage of
patients who achieve the highest or lowest possible scores
of a particular PRO instrument. Ideally, a PRO tool would
have few patients achieving the extremes to stratify
patients appropriately. Our study demonstrated a large
ceiling effect with the PROMIS UE, especially at 6 months
TABLE 3
Ceiling and Floor Effects of PRO Instrumentsa
Preoperative 6 wk 6 mo 2 y
Ceiling Floor Ceiling Floor Ceiling Floor Ceiling Floor
ASES 2.8 0.0 0.0 0.0 23.6 0.0 39.0 0.0
WOSI 0.0 0.0 0.0 0.0 2.8 0.0 3.0 0.0
SF-36 PF 13.9 0.0 0.0 0.0 41.7 0.0 69.0 0.0
EQ-5D 13.9 0.0 11.3 0.0 48.6 0.0 39.0 0.0
PROMIS PF CAT 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0
PROMIS UE 23.6 0.0 4.2 0.0 68.1 0.0 67.0 0.0
Subgroup analyses
PROMIS UE CAT v 2.0 — — — — — — 44.0 0.0
PROMIS UE 21 y 29.0 0.0 8.1 0.0 71.1 0.0 81.0 0.0
aData are reported as percentage of patients. The presence of a ceiling effect was defined as >15% of patients achieving the maximum
possible score. ASES, American Shoulder and Elbow Surgeons; PRO, patient-reported outcome; PROMIS PF CAT, Patient-Reported Out-
comes Measurement Information System Physical Function computer adaptive test; PROMIS UE, Patient-Reported Outcomes Measurement
Information System Upper Extremity; SF-36 PF, 36-Item Short Form Health Survey physical function; WOSI, Western Ontario Shoulder
Instability Index.
TABLE 2
Effect Size and SRM of PRO Instruments Between Study Time Pointsa
Preoperatively to 6 wk Preoperatively to 6 mo
Effect Size (95% CI) SRM (95% CI) Effect Size (95% CI) SRM (95% CI)
ASES –0.41 (–0.70 to –0.13) –0.34 (–0.63 to –0.06) 1.27 (0.93 to 1.60) 1.04 (0.72 to 1.36)
WOSI 0.09 (–0.18 to 0.36) 0.08 (–0.20 to 0.34) 1.83 (1.44 to 2.21) 1.74 (1.37 to 2.12)
Marx 0.25 (0.04 to 0.46) 0.29 (0.08 to 0.50) 0.07 (–0.12 to 0.26) 0.08 (–0.10 to 0.28)
SF-36 PF –1.20 (–1.52 to –0.89) –1.14 (–1.45 to –0.83) 0.69 (0.45 to 0.94) 0.73 (0.48 to 0.98)
EQ-5D –0.12 (–0.38 to 0.14) –0.11 (–0.38 to –0.15) 0.85 (0.55 to 1.15) 0.73 (0.44 to 1.02)
PROMIS PF CAT –0.94 (–1.27 to –0.61) –0.75 (–1.07 to –0.43) 0.76 (0.44 to 1.08) 0.59 (0.29 to 0.91)
PROMIS UE –1.05 (–1.27 to –0.74) –0.98 (–1.28 to –0.68) 1.09 (0.77 to 1.41) 0.92 (0.61 to 1.23)
aValues were defined as small (absolute value of 0.2), medium (absolute value of 0.5), or large (absolute value of 0.8). ASES, American
Shoulder and Elbow Surgeons; EQ-5D, EuroQol–5 Dimensions; PRO, patient-reported outcome; PROMIS PF CAT, Patient-Reported Out-
comes Measurement Information System Physical Function computer adaptive test; PROMIS UE, Patient-Reported Outcomes Measurement
Information System Upper Extremity; SF-36 PF, 36-Item Short Form Health Survey physical function; SRM, standardized response mean;
WOSI, Western Ontario Shoulder Instability Index.
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and 2 years postoperatively, which is not unexpected if
a patient’s pain and function improve after surgery. This
effect was more dramatic in patients aged21 years, which
was also detected in preoperative patients.3 Other studies
have also suggested that the PROMIS UE seems to focus on
lower levels of function, which is problematic when trying
to evaluate young and healthy populations.9 Such ceiling
effects were not present in other studies using the PROMIS
UE, including patients with rotator cuff tears2,16 or those
undergoing shoulder arthroplasty,6 who represent older
and likely less functional populations. The PROMIS UE
has subsequently been expanded to a CAT to include 46
items (PROMIS UE CAT v 2.0). We had a subgroup of
patients (n ¼ 18) complete this version at 2 years postoper-
atively, and although this improved the percentage of
patients hitting the ceiling effect, 44.0% of this group still
achieved the maximum score. This means that the PRO-
MIS UE and PROMIS UE CAT v 2.0 will not be able to
detect higher levels of function in these patients and would
need to be revised, or other PRO tools such as the Kerlan-
Jobe Orthopaedic Clinic overhead athlete shoulder and
elbow scale1 should be utilized in conjunction with this.
There are several limitations to this study. First, we had
incomplete longitudinal data among the patients who had
outcome scores at 2 years postoperatively, necessitating
cross-sectional analysis at this time point. Therefore,
although we were able to measure the correlation of the
PROMIS with legacy PRO instruments as well as ceiling
and floor effects at 2 years postoperatively, we could not
assess responsiveness to change at this time point. Along
with this, the longitudinal group was only evaluated to
6 months in the postoperative period, which is near the
time to return to full activity. Therefore, conclusions can
only be drawn about the correlation of the PROMIS with
other PRO instruments at this time point and beyond. Sec-
ond, all patients were required to complete multiple PRO
tools at each visit, and questionnaire fatigue may have had
an influence on our results. However, in a study conducted
on these patients preoperatively, it was found that the
order in which the surveys were filled out had no significant
influence on the results.3 In the current study, approxi-
mately half the patients filled out PROMIS questions first,
and half filled them out last. Third, the population of
patients was heterogeneous in terms of the type of shoul-
der stabilization procedure performed secondary to our
methods of data extraction from our prospective database
that includes patients based on diagnosis (shoulder insta-
bility) rather than procedure. The procedures investigated
in the current study were heavily skewed to represent
arthroscopic stabilization procedures. Although we were
able to perform a small subgroup analysis on patients who
had used the expanded PROMIS UE CAT v 2.0, further
studies are warranted to assess this updated tool. Finally,
this study did not address one of the most important out-
comes in shoulder instability: recurrence. An additional
study is warranted to assess the correlation of the
TABLE 4
Correlation of PROMIS PF CAT and PROMIS UE With Other PRO Instrumentsa
Preoperative 6 wk 6 mo 2 y
PROMIS UE
Convergent validity
ASES 0.76 (P < .01) 0.73 (P < .01) 0.54 (P < .01) 0.58 (P < .01)
WOSI 0.60 (P < .01) 0.62 (P < .01) 0.48 (P < .01) 0.58 (P < .01)
SF-36 PF 0.70 (P < .01) 0.68 (P < .01) 0.56 (P < .01) 0.54 (P < .01)
PROMIS PF CAT 0.57 (P < .01) 0.47 (P < .01) 0.59 (P < .01) 0.54 (P < .01)
Divergent validity
SF-36 GH 0.32 (P < .10) 0.20 (P ¼ .10) 0.18 (P ¼ .12) 0.38 (P < .01)
EQ-5D 0.63 (P < .01) 0.59 (P < .01) 0.46 (P < .01) 0.55 (P < .01)
Marx 0.11 (P ¼ .37) 0.06 (P ¼ .61) 0.26 (P ¼ .03) 0.30 (P < .01)
PROMIS PF CAT
Convergent validity
ASES 0.67 (P < .01) 0.33 (P < .01) 0.52 (P < .01) 0.64 (P < .01)
WOSI 0.53 (P < .01) 0.32 (P < .01) 0.60 (P < .01) 0.62 (P < .01)
SF-36 PF 0.65 (P < .01) 0.61 (P < .01) 0.68 (P < .01) 0.64 (P < .01)
PROMIS UE 0.57 (P < .01) 0.47 (P < .01) 0.59 (P < .01) 0.53 (P < .01)
Divergent validity
SF-36 GH 0.46 (P < .01) 0.23 (P ¼ .05) 0.33 (P < .01) 0.49 (P < .01)
EQ-5D 0.53 (P < .01) 0.25 (P ¼ .04) 0.43 (P < .01) 0.50 (P < .01)
Marx 0.07 (P ¼ .58) 0.14 (P ¼ .23) 0.21 (P ¼ .07) 0.35 (P < .01)
aThere was general convergent validity with other instruments focused on physical function and divergent validity with instruments
aimed to measure general health. Correlations were defined as excellent (>0.7, black shading), excellent-good (0.61-0.7, dark gray shading),
good (0.4-0.6, light gray shading), or poor (0.2-0.39, no shading). ASES, American Shoulder and Elbow Surgeons; EQ-5D, EuroQol–5 Dimen-
sions; PRO, patient-reported outcome; PROMIS PF CAT, Patient-Reported Outcomes Measurement Information System Physical Function
computer adaptive test; PROMIS UE, Patient-Reported Outcomes Measurement Information System Upper Extremity; SF-36 GH, 36-Item
Short FormHealth Survey general health; SF-36 PF, 36-Item Short FormHealth Survey physical function; WOSI, Western Ontario Shoulder
Instability Index.
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PROMIS and other PRO tools in evaluating outcomes in
patients with and without recurrent shoulder instability.
CONCLUSION
The PROMIS PF CAT and PROMIS UE correlated well
with previously validated tools in patients with shoulder
instability. Both tools demonstrated the ability to detect
meaningful change before and after operative interventions
for shoulder instability. The PROMIS UE demonstrated
ceiling effects at all time points, but no ceiling effect was
found for the PROMIS PF CAT. The PROMIS PF CAT can
be considered in place of the SF-36 PF. The PROMIS UE or
PROMIS UE CAT v 2.0 may not have the ability to stratify
higher levels of function, especially in patients aged
21 years, and should not be utilized at this time.
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